PG
MED icon

PEAK6 Group’s Medifast MED Stock Holding History

PEAK6 Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-9,400
Closed -$558K – 4495
2017
Q3 		$558K Buy
9,400
+4,300
+84% +$214K ﹤0.01% 2471
2017
Q2 		$211K Sell
5,100
-4,900
-49% -$213K ﹤0.01% 3297
2017
Q1 		$444K Buy
+10,000
New +$430K ﹤0.01% 2362
2016
Q4 		– Sell
-2,400
Closed -$91K – 4927
2016
Q3 		$91K Buy
2,400
+1,500
+167% +$53.8K ﹤0.01% 3624
2016
Q2 		$30K Buy
+900
New +$29K ﹤0.01% 3986
2016
Q1 		– Sell
-48,900
Closed -$1.49M – 4786
2015
Q4 		$1.49M Buy
+48,900
New +$1.46M 0.01% 1589
2015
Q1 		– Sell
-34,600
Closed -$1.16M – 5027
2014
Q4 		$1.16M Buy
34,600
+10,100
+41% +$315K 0.01% 1816
2014
Q3 		$804K Buy
+24,500
New +$752K 0.01% 2027
2014
Q2 		– Sell
-4,400
Closed -$128K – 4913
2014
Q1 		$128K Buy
+4,400
New +$118K ﹤0.01% 3761

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

PEAK6 Group's MED Position: Q3 2017 in Review

PEAK6 Group sold out of Medifast (MED) in Q3 2017, closing a stake of 7,743 shares — an estimated $385K sold.

PEAK6 Group first reported a position in MED in Q4 2014 and held it in 4 quarters. The position peaked at $578K in Q4 2015. 168 funds tracked by Wall St. Rank hold MED as of Q3 2017.

  • PEAK6 Group reported no remaining Medifast position as of Q3 2017 after selling out during the quarter.
  • PEAK6 Group sold 7,743 Medifast shares in Q3 2017, an estimated $385K.
  • PEAK6 Group first reported a position in Medifast in Q4 2014 and held it in 4 quarters.
  • PEAK6 Group's Medifast position peaked at $578K in Q4 2015.
  • 168 funds tracked by Wall St. Rank held Medifast as of Q3 2017.

Based on PEAK6 Group's 13F filing for Q3 2017, filed 14 Nov 2017.